Navigation Links
Grunenthal Group Acquires Pain Patent Portfolio From Nectid, Inc.
Date:3/22/2011

PRINCETON, N.J., March 22, 2011 /PRNewswire/ -- Nectid, Inc. (www.nectid.com) announced today that it has completed the sale of a number of patents and patents-applications to Grunenthal GmbH (www.grunenthal.com), a European specialty pharmaceutical company that is a pioneer in pain drug discovery and research. The patent portfolio includes a number of novel chemical entities from Nectid's Pain Drug Discovery program and two key drug delivery platforms (www.nectid.com/pipeline_newdrug).

Dr. Veena Rao, President and CEO of Nectid, said, "We are very happy with this patent sale transaction with Grunenthal. This is the second patent deal Nectid has completed in the last 12 months and the patents are among the nineteen of our patents that have been acquired by big pharmaceutical companies in the last two years. We have accumulated a portfolio of 110 NCEs for pain and depression and we expect to file an IND for at least one drug candidate within the next 6-9 months."

About Nectid, Inc.

Based in Princeton, New Jersey, Nectid is a privately held drug discovery company with primary focus on developing novel drug delivery products and novel chemical entities for two therapeutic areas that use one or more common biochemical pathways- Pain and Depression. Nectid applies its deep understanding pain receptor science to develop novel drug candidates that target mu-opioid receptor, norepinephrine reuptake and alpha2delta or NMDA pathways. For more information, visit www.nectid.com.


'/>"/>
SOURCE Nectid, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Introducing the Access Group and Its New Business Entities
2. MiMedx Group, Inc. to Present at the 10th Annual Needham Healthcare Conference
3. PR Newswire and BIOCOM Purchasing Group Announce Renewal of Exclusive Partnership
4. Apexigen Announces the Filing by its Partner, Simcere Pharmaceutical Group, of First IND
5. BioNeutral Group Secures Three Initial Trial Orders for its Ogiene™ Odor Neutralizer & Multi-Purpose Cleaner Product Line
6. Photonic Products Group, Inc. Announces New Sales and Marketing VP
7. NeoStem to Present at Cowen Group 31st Annual Health Care Conference on March 7 and 8
8. Healthzone Limited Engages The Trout Group for Investor Relations Services
9. BioNeutral Group to Receive Economic Development Incentives
10. 74 Percent EBITDA Improvement at Zeltia Group in 2010
11. Polaris Group and The Ludwig Institute for Cancer Research Ltd Initiate Phase 2 Trial of Amino-Acid Degrading Enzyme, ADI-PEG 20, in Patients with Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Ca (PRWEB) , ... March 28, 2017 , ... Mass ... settings. The utilization of this technology is driven by its potential to perform challenging ... there are also some challenges that must be addressed for it to be routinely ...
(Date:3/28/2017)... ... March 28, 2017 , ... Benchworks ... March 22 in Philadelphia. The event was offered by the Chamber of Commerce ... featured breakout groups and interaction with speakers who are leaders in their ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the Modular Building Institute (MBI), an international modular trade organization, were awarded First ... category for the Pagliuca Life Lab at Harvard University. The awards were presented ...
(Date:3/28/2017)... WASHINGTON , March 28, 2017 /PRNewswire/ ... launch single-cell sequencing during the American Association for Cancer ... Convention Center in Washington, D.C. , ... differential gene expression of thousands of cells at the ... Experts on-hand at AACR to discuss ...
Breaking Biology Technology:
(Date:3/20/2017)... 20, 2017 PMD Healthcare announces the release ... Wellness Management System (WMS), a remote, real-time lung health ... PMD Healthcare is a Medical Device, Digital Health, and ... to creating innovative solutions that empower people to improve ... focus, PMD developed the first ever personal spirometer, Spiro ...
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , ... Well Made Simple," and 23andMe , the leading ... better food choices.  Zipongo can now provide customers with ... preferences, health goals and biometrics, but also genetic markers ... choices. Zipongo,s personalized food decision support platform ...
(Date:3/2/2017)... Summary This report provides all the information you ... activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... an in-depth insight into the partnering activity of one of ... company reports are prepared upon purchase to ensure inclusion of ...
Breaking Biology News(10 mins):